Literature DB >> 19545759

Primary cultures from rat vibrissae as a potential cell source for in vitro construction of urinary bladder wall grafts.

T Drewa1, R Joachimiak, A Kaznica, V Sarafian, J Sir.   

Abstract

BACKGROUND: In vitro-constructed grafts can be used for human bladder augmentation. There are many diseases in which autologous cells cannot be used for this purpose. The aim of the present study was to examine the potential of rat vibrissae hair follicle cells to form cultures, which could serve as a source for in vitro creation of urinary bladder wall grafts.
METHODS: Two hundred vibrissae were excised from young Wistar male rats. Two different digestions were performed, in dispase and in collagenase. All follicles were additionally incubated in trypsin and ethylenediamine tetraacetic acid. Two different culture media based on DMEM (Dulbecco's Modified Eagle's Medium) were used: the first was supplemented with keratinocyte growth factor (KGF) and the second with epidermal growth factor. Immunocytochemical detection of cytokeratin, CD34, p63, Ki-67 (proliferation index), and HMB45 (Human Melanoma Black 45) was performed.
RESULTS: Forty-eight primary cultures of rat follicle vibrissae cells were established from 200 hair follicles (24% successful rate). Twenty-four primary cultures were obtained after dispase digestion and 24 after collagenase treatment. Each group was cultured in 2 different media. A heterogeneity of primary cultures was observed. Cells formed a monolayer within a period of 2 to 4 weeks. The 24 primary cultures established after dispase treatment exhibited monolayers of small cuboid cells expressing cytokeratin and CD34. In the 40th passage 20%-40% of cells expressed p63; 85% of these cells from late passages were positive for Ki-67, indicating preserved mitotic potential. Epithelial-like phenotype was observed after dispase digestion and cultivation in KGF-supplemented medium. After 3 weeks, the morphology of these cells changed into fibroblast-like. These cultures were negative for CD34. Fibroblast-like cell growth was observed after collagenase treatment in both KGF- and EGF-supplemented media. These cells were positive for the melanocyte cell marker (HMB45).
CONCLUSIONS: Culture media and isolation conditions influence hair follicle stem cell differentiation. The stem cell niche within the hair follicles is a reservoir of cells, which can be potentially used for in vitro creation of urinary bladder wall grafts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545759     DOI: 10.1016/j.transproceed.2009.02.091

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

Review 1.  Stem cell therapy for incontinence: where are we now? What is the realistic potential?

Authors:  Charuspong Dissaranan; Michelle A Cruz; Bruna M Couri; Howard B Goldman; Margot S Damaser
Journal:  Curr Urol Rep       Date:  2011-10       Impact factor: 3.092

Review 2.  Tissue engineering for the oncologic urinary bladder.

Authors:  Tomasz Drewa; Jan Adamowicz; Arun Sharma
Journal:  Nat Rev Urol       Date:  2012-08-21       Impact factor: 14.432

3.  The histocompatibility research of hair follicle stem cells with bladder acellular matrix.

Authors:  Jia Li; Wenguang Wang; Jiuzhi Li; Mulati Rexiati; Henqing An; Feng Wang; Yujie Wang
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 4.  Bulge Region as a Putative Hair Follicle Stem Cells Niche: A Brief Review.

Authors:  Sanaz Joulai Veijouye; Abazar Yari; Fatemeh Heidari; Nayereh Sajedi; Fatemeh Ghoroghi Moghani; Maliheh Nobakht
Journal:  Iran J Public Health       Date:  2017-09       Impact factor: 1.429

5.  Effect of Cinnamomum osmophloeum Kanehira Leaf Aqueous Extract on Dermal Papilla Cell Proliferation and Hair Growth.

Authors:  Tung-Chou Wen; Yuan-Sheng Li; Karthyayani Rajamani; Horng-Jyh Harn; Shinn-Zong Lin; Tzyy-Wen Chiou
Journal:  Cell Transplant       Date:  2018-02       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.